Clinical Trials Directory

Trials / Active Not Recruiting

Active Not RecruitingNCT06697392

Ultrasound-based Artificial Intelligence for Classification of Carpal Tunnel Syndrome

Ultrasound-based Artificial Intelligence for Grading of Carpal Tunnel Syndrome, a Multicenter Study in China

Status
Active Not Recruiting
Phase
Study type
Observational
Enrollment
500 (estimated)
Sponsor
Peking University People's Hospital · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

Carpal tunnel syndrome (CTS) is one of the most prevalent peripheral neuropathies, impacting approximately 4% of the general population. It is typically classified into three degrees: mild, moderate, and severe. Accurate grading of carpal tunnel syndrome (CTS) is essential for determining appropriate treatment options, thereby playing a crucial role in optimizing patient outcomes. Electrophysiological testing (EST) is a key parameter for grading carpal tunnel syndrome (CTS). However, it is limited by several factors, including its invasive nature, poor reproducibility, and reduced sensitivity for detecting early-stage disease. Recently, ultrasound has gained widespread acceptance among clinicians for the assessment and grading of CTS. Nonetheless, radiologists often encounter challenges in this process due to the variability in image quality, differences in experience, and inherent subjectivity. To address these issues, artificial intelligence presents a promising solution. Therefore, this study aims to develop a deep learning model for grading CTS by leveraging multimodal imaging features, including B-mode ultrasound, superb microvascular imaging (SMI), and elastography. Additionally, the investigators intend to validate the model's effectiveness by testing it with images from various clinical centers, ensuring its generalizability across different clinical settings.

Conditions

Interventions

TypeNameDescription
OTHERultrasound examinationThe investigators intend to perform ultrasound examinations for the participants with CTS.

Timeline

Start date
2024-11-15
Primary completion
2025-06-30
Completion
2026-12-30
First posted
2024-11-20
Last updated
2024-11-20

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT06697392. Inclusion in this directory is not an endorsement.